SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-257170
Filing Date
2020-09-29
Accepted
2020-09-29 07:08:10
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d72033d6k.htm 6-K 11668
2 EX-99.1 d72033dex991.htm EX-99.1 100447
3 EX-99.2 d72033dex992.htm EX-99.2 529340
  Complete submission text file 0001193125-20-257170.txt   6582399

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mreo-20200630.xml EX-101.INS 1735082
5 XBRL TAXONOMY EXTENSION SCHEMA mreo-20200630.xsd EX-101.SCH 82404
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mreo-20200630_cal.xml EX-101.CAL 46889
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20200630_def.xml EX-101.DEF 308714
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20200630_lab.xml EX-101.LAB 463208
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20200630_pre.xml EX-101.PRE 414209
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 201206005
SIC: 2834 Pharmaceutical Preparations